Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

RCT (n=673) reports ultra-rapid lispro compared with lispro in a basal-bolus regimen was non-inferior for HbA1c improvement (estimated treatment difference 0.06%, 95% CI −0.05; 0.16) and superior to lispro for postprandial glucose control.

Source:

Diabetes Care